TCL Archive Kennedy Plans One Year Act Renewal, Followed By Three Year Bill; Hearing Scheduled Feb. 8 February 3, 1978
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Ohio State Becomes 18th Comprehensive Center; UCLA Needs Only To Overcome “Minor” Problems April 16, 1976